Business and Finance

Deloitte unveils ExaLink, a cloud-based commercial-compliance portal

September 22, 2016

CIS by Deloitte seeks to provide a comprehensive service for revenue management

Much heat, little new light in Mylan’s Congressional hearing over EpiPen pricing

September 22, 2016

Mylan CEO sticks to authorized-generic strategy for price relief

Global pharma market will reach $1.12 trillion in 2022

September 18, 2016

Roche could overtake Novartis as the No. 1 global firm by then, says Evaluate Pharma

Drug pricing brawl turns to PBMs

September 17, 2016

Pharmacy benefit managers feel some marketplace heat even as they establish new benefit programs

Walgreens Boots Alliance continues its consolidation of pharma distribution

September 08, 2016

Walgreens-Rite Aid merger is still pending

When is a branded drug a generic? When it is sold by Mylan…

September 03, 2016

EpiPen controversy has a new twist: paying lower rebates to state Medicaid programs

A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy

September 01, 2016

Moving From Big Pharma To A Small Company? You May Be In For A Few Surprises

September 01, 2016

Sponsored by TGaS Advisors

Mylan’s EpiPen re-energizes drug pricing disputes

August 25, 2016

Presidential politicking adds momentum to the growing backlash, and not just for Mylan

Where are those missing billions in new-product pharma sales?

August 12, 2016

Healthcare research firm calls out the alarmist predictions over PCSK9s and other new drugs